Brief: Mink Therapeutics Regains Compliance With Nasdaq Capital Market Requirement
31/07/2024 12:34
July 31 (Reuters) - Mink Therapeutics Inc INKT.O :
* MINK THERAPEUTICS REGAINS COMPLIANCE WITH NASDAQ CAPITAL
MARKET
REQUIREMENT
Source text for Eikon: ID:nGNX1vlsKD
Further company coverage: INKT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mink Therapeutics
See all newsMiNK Therapeutics Q2 loss narrows on expense discipline
Brief: MiNK Therapeutics Q2 EPS USD -0.62
Mink Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: MiNK Therapeutics Says No Major Serious Adverse Events Attributed To Agent-797 In First Patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's